No longer trades. Fund positions are valued at its last close, $0.7400 on Sep 8, 2026. View SEC filing
BRNS (BARINTHUS BIOTHERAPEUTICS PL) is held by 9 institutional investors as of Q2 2026. Top institutional shareholders: M&G Plc ($5.2M), MORGAN STANLEY ($71,837), Baird Financial Group, Inc. ($69,934).
Who's Trading
Source dates: Price Sep 8, 2026 · Insiders Sep 9, 2026 · Activists Sep 11, 2026 · Congress none
Top Holders
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about BRNS
Who owns BRNS?
9 institutional investors held BRNS on June 30, 2026, led by M&G Plc ($5.2M), MORGAN STANLEY ($71,837) and Baird Financial Group, Inc. ($69,934).
How many hedge funds hold BRNS?
9 institutional investors reported BRNS in their 13F filings for the quarter ended June 30, 2026, $5.4M in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer